Literature DB >> 20707209

[Research of coptis effect on incidence of neonatal jaundice based on Cox model].

Rongtian Wang1, Na Lin.   

Abstract

OBJECTIVE: To learn the effects of coptis in treating neonatal jaundice and to find the index that guides the clinical administration of the medicine.
METHOD: Clinical data of 412 cases of neonatal jaundice were studied retrospectively, and univariate and multivariate analysis were made to the factors affecting the incidence according to the Cox model which led to the establishment of the predictive equation. According to the regression coefficients, the relative risk, wald value, the coptis effects were evaluated on the incidence of neonatal jaundice. RESULT: Single-factor Cox model analysis shows that there are five main factors affecting the incidence of neonatal jaundice, Multivariate Cox model analysis indicates that the five main factors are also independent factors that affect the incidence, the roles of which, ranking from minor to major are, in turn, age, applied coptis, ethnic, G6PD deficiency and cesarean section. Among them, the regression coefficient is -0.259, relative risk 0.772, wald value 6.832. It sugguests that coptis may reduce the incidence of neonatal jaundice, and that it is a protective factor. The prediction equation, by regression coefficients, which has been used to establish the incidence of neonatal jaundice, is as following: h(t, x) = h0 (t) exp (- 0.022 x2 - 0.494x3 + 0.344x8 + 0.226x9 - 0.259x10).
CONCLUSION: Coptis is one of the important factors that affect the occurrence of neonatal jaundice, and it has a protective effect in preventing neonatal jaundice from occurrence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20707209     DOI: 10.4268/cjcmm20101025

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  1 in total

Review 1.  From prejudice to evidence: the case of rhizoma coptidis in singapore.

Authors:  Chin Ee Ho; You Li Goh; Chang Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2014-12-25       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.